JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 29, 2008; DOI: 10.1124/jpet.107.131607


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.131607v1
325/3/850    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, H. J.
Right arrow Articles by Thayer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H. J.
Right arrow Articles by Thayer, S.


Received for publication September 12, 2007.
Revised February 27, 2008.
Accepted for publication February 27, 2008.

Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture

Hee Jung Kim 1, Jonathan J. Waataja 1, Stanley Thayer 1*

1 University of Minnesota

* Address correspondence to: E-mail: sathayer{at}umn.edu

Abstract

Dendritic pruning and loss of synaptic contacts are early events in many neurodegenerative diseases. These effects are dynamic and appear to differ mechanistically from the cell death process. Cannabinoids modulate synaptic activity and afford protection in some neurotoxicity models. We investigated the effects of cannabinoids on activity-induced changes in the number of synapses between rat hippocampal neurons in culture. Morphology and synapses were visualized by confocal imaging of neurons expressing DsRed2 and postsynaptic density protein 95 fused to enhanced green fluorescent protein (PSD95-GFP). Reducing the extracellular Mg2+ concentration to 0.1 mM for 4 hr induced intense synaptic activity that decreased the number of PSD95-GFP puncta by 45 ± 13 %. Synapse loss was an early event, required activation of NMDA receptors and was mediated by the ubiquitin-proteasome pathway. The cannabinoid receptor full agonist (R)-(+)-[2,3-dihydro-5-methyl-3-[(4-morpholinyl)methyl] pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl](1-napthalenyl)methanone monomethanesulfonate (WIN55,212-2; EC50=2.5±0.5 nM) and the partial agonist {Delta}9-tetrahydrocannabinol (THC; EC50=9±3 nM) inhibited PSD loss in a manner reversed by the CB1 receptor antagonist rimonabant. The protection was mimicked by inhibition of presynaptic Ca2+ channels and WIN55,212-2 did not prevent PSD loss elicited by direct application of glutamate, suggesting a presynaptic mechanism. Prolonged exposure to WIN55,212-2, but not THC, desensitized the protective effect. Treating cells that had undergone PSD loss with WIN55,212-2 reversed the loss and enabled recovery of a full compliment of synapses. The modulation of synaptic number by acute and prolonged exposure to cannabinoids may account for some of the effects of these drugs on the plasticity, survival and function of neural networks.


Key words: PSD95, THC, Win55,212, cannabinioid, excitotoxicity, synapse





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.